https://www.selleckchem.com/pr....oducts/alflutinib-as
A statistically significantly lower Hb in CRC patients was discernable 609 days (20 months) prior to diagnosis for men and 905 days (30 months) for women, both in the range of normal Hb. The frequency of Hb testing in the general population primary care was surprisingly low, and was ≥50% annually only in octogenarians. The findings indicate a potential for Hb trends to inform the diagnostic process of CRC but whether it will translate into any clinical advantage is yet uncertain. The findings indicate a potential for
Like
Comment
Share
